Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fluidigm Corp (NASDAQ:FLDM)

3.55
Delayed Data
As of Aug 22
 -0.21 / -5.59%
Today’s Change
2.52
Today|||52-Week Range
9.65
-51.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$110.6M

Company Description

Fluidigm Corp. engages in the development, manufacture, and market of microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 243-6628

Employees

Shareholders

Other institutional69.41%
Individual stakeholders42.70%
Mutual fund holders40.98%

Top Executives

Stephen Christopher LinthwaitePresident, CEO, Chief Operating Officer & Director
Vikram JogChief Financial Officer
Nicholas S. KhadderSecretary & Chief Compliance Officer
Jennifer Ling LeePrincipal Accounting Officer, VP & Controller
Steven C. McPhailChief Commercial Officer